SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer

Potent Inhibition of Macropinocytosis by Niclosamide in Cancer Cells: A Novel Mechanism for the Anticancer Efficacy for the Antihelminthic

(2023) Souad R. Sennoune et al.   Cancers

Exosomal miRNAs as next-generation therapy vehicles in Breast Cancer

(2023) Reena V. Saini et al.   CURRENT GENE THERAPY

Research progress on the role of cationic amino acid transporter (CAT) family members in malignant tumors and immune microenvironment

(2023) Shijing You et al.   AMINO ACIDS

Temporal patterns of breast cancer incidence, mortality, disability-adjusted life years and risk factors in 12 South American Countries, 1990–2019: an examination using estimates from the global burden of disease 2019 study

(2023) Rajesh Sharma   BREAST CANCER RESEARCH AND TREATMENT

Artificial intelligence in breast imaging: potentials and challenges

(2023) Jiawei Li et al.   PHYSICS IN MEDICINE AND BIOLOGY

Identification of potential key genes of TGF-beta signaling associated with the immune response and prognosis of ovarian cancer based on bioinformatics analysis

(2023) Xiaoxue Zhang et al.   Heliyon

Cancer statistics, 2022

(2022) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer

(2021) Tyler Sniegowski et al.   Pharmaceuticals

Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue

(2021) Vrinda Gote et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Epigenetic mechanisms in breast cancer therapy and resistance

(2021) Liliana Garcia-Martinez et al.   Nature Communications

Expression and function of SLC38A5, an amino acid-coupled Na+/H+ exchanger, in triple-negative breast cancer and its relevance to macropinocytosis

(2021) Sabarish Ramachandran et al.   BIOCHEMICAL JOURNAL

A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs

(2020) Enrico Girardi et al.   Nature Chemical Biology

Glutamine for Amelioration of Radiation and Chemotherapy Associated Mucositis during Cancer Therapy

(2020) Peter M. Anderson et al.   Nutrients

Glutamine reliance in cell metabolism

(2020) Hee Chan Yoo et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer

(2020) Deanna N. Edwards et al.   JOURNAL OF CLINICAL INVESTIGATION

Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge

(2019) Nedeljković et al.   Cells

Periodic fasting starves cisplatin‐resistant cancers to death

(2018) Novella Guidi et al.   EMBO JOURNAL

The glutamine-alpha-ketoglutarate (AKG) metabolism and its nutritional implications

(2016) Dingfu Xiao et al.   AMINO ACIDS

Glutamine transporters in mammalian cells and their functions in physiology and cancer

(2016) Yangzom D. Bhutia et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Cancer metabolism: a therapeutic perspective

(2016) Ubaldo E. Martinez-Outschoorn et al.   Nature Reviews Clinical Oncology

Regulation of Glutamine Carrier Proteins by RNF5 Determines Breast Cancer Response to ER Stress-Inducing Chemotherapies

(2015) Young Joo Jeon et al.   CANCER CELL

MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis

(2013) Atsushi Terunuma et al.   JOURNAL OF CLINICAL INVESTIGATION

Control of glutamine metabolism by the tumor suppressor Rb

(2013) M R Reynolds et al.   ONCOGENE

Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake

(2010) Valentina K. Todorova et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

(2009) Ping Gao et al.   NATURE